Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical XZ.700 dose-ranging study in mild to moderate atopic dermatitis
NL-OMON54877Phase 1Active, not recruiting
- Sponsor
- Micreos
- Start
- Sep 2020
- Modality
- Metabolic Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of XZ.700 in atopic dermatitis (AD) (4 arms), sponsored by Micreos. Started Sep 2020; status: active, not recruiting.
02
Drugs
XZ.700
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON54877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54877.